Loading news...
Nestle CEO Philipp Navratil has apologised to the Swiss company's customers over the recall in dozens of countries of some batches of infant nutrition products.
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Nestlé S.A. (OTC: NSRGY) resulting from allegations that Nestlé may have issued materially misleading business information to the investing public. So What: If you purchased Nestlé securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen L.
I present my top 10 high-yield dividend-paying companies for 2026, emphasizing sustainable income, growth, and capital appreciation. Selections include AXA, Allianz, PepsiCo, Verizon, Nestlé, Realty Income, VICI Properties, Altria, Chevron, and Petrobras, all meeting strict yield, valuation, and size criteria. These companies offer attractive forward dividend yields, strong dividend growth records, competitive industry positioning, and current valuations that provide a margin of safety.
The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
Nestle said it is not aware of any illnesses linked to the products, but it is advising parents not to feed the formula to infants or young children.
Nestle's recall of some batches of infant nutrition products has widened beyond Europe to the Americas and Asia, including China and Brazil, a tally from the company and national health ministry statements show.
Nestle recalled specific batches of its SMA baby formula, citing the potential presence of cereulide bacteria.
Food producer Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
Nestle said on Tuesday it had completed the sale of its remaining 40% stake in packaged meat business Herta Foods to Spanish company Casa Tarradellas.
Nestle views its stake in L'Oreal as a financial investment, and while it is regularly reviewed, there is nothing new to report on the matter, Nestle CEO Philipp Navratil was quoted as saying on Tuesday.
Nestlé (OTCPK:NSRGY) remains a solid Buy, supported by sustainable dividends and a favorable valuation gap versus historical multiples. Recent margin pressure stems from elevated coffee and cocoa input costs, but easing commodity prices and aggressive cost savings support a mid-term margin rebound. Free cash flow conversion has moderated, lowering the DCF spot estimate to CHF 90-100 versus a share price of still under CHF 80. Dividends remain well covered.
Shares of Nestlé S.A. (OTCMKTS:NSRGF - Get Free Report) shot up 2.7% on Wednesday. The stock traded as high as $100.80 and last traded at $100.80. 5,577 shares traded hands during mid-day trading, a decline of 70% from the average session volume of 18,663 shares. The stock had previously closed at $98.1280. Nestlé Stock
The city of San Francisco filed a lawsuit against some of the nation's top food manufacturers on Tuesday, arguing that ultraprocessed food from the likes of Coca-Cola and Nestle are responsible for a public health crisis.City Attorney David Chiu named 10 companies in the lawsuit, including the makers of such popular foods as Oreo cookies, Sour Patch Kids, Kit Kat, Cheerios and Lunchables. The lawsuit argues that ultraprocessed foods are linked to diseases such as Type 2 diabetes, fatty liver disease and cancer.
Nestlé presents a turnaround opportunity with a new CEO, an updated cost transformation plan, and improved 2025 guidance. NSRGY targets CHF 3 billion in cost savings by 2027, including significant workforce reductions and reinvestment to accelerate growth. Macro factors like US rate cuts and tariffs could serve as catalysts, but execution and external risks remain for the company.
Swiss food giant Nestlé is working with investment bank Morgan Stanley to review options, including a potential sale, of its Blue Bottle Coffee chain, according to three sources familiar with the matter.
A French court rejected on Tuesday a case against Nestle's Perrier mineral water brought by a consumers group who demanded the sparking water be withdrawn from markets.
Nestle wants out of mass-market vitamins. But a move by consumers towards more expensive, science-backed products risks complicating the Swiss conglomerate's effort to fetch a high price for its underperforming brands.
The International Equity ADR composite rose 3.0% gross of fees in the second quarter, behind the 7.0% gain of the MSCI ACWI ex US Index. In Communication Services, Tencent delivered a second consecutive quarter of double-digit revenue and profit growth. Japan was the largest detractor, with Chugai and Sysmex weighing on results.
Nestlé delivered solid Q3 results, with sequential organic sales growth across all regions despite FX headwinds and US category softness. Management reaffirmed 2025 and medium-term targets, aiming for at least a 16% operating margin in 2025 and a 17%+ margin over the medium term. A global headcount reduction of ~16,000 is planned, doubling annual savings to CHF 1 billion by 2027, supporting margin expansion and transformation.
European markets closed higher on Thursday after a volatile week marked by political tension in France, new data from the UK showing modest economic growth, and a sweeping restructuring announcement from Nestlé. Gains across major bourses were broad-based, led by food and beverage stocks, which surged following Nestlé's sharp rebound. Stoxx 600 climbs as Nestlé